Alcohol and fat promote steatohepatitis: A critical role for fat-specific protein 27/CIDEC

Journal of Investigative Medicine

Volumn 64, Issue 6, 2016, Pages 1078-1081

  Liangpunsakul, Suthat ^a,b   Gao, Bin ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; FAT; FAT SPECIFIC PROTEIN 27; PROTEIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ALCOHOL LIVER DISEASE; ANIMAL MODEL; ARTICLE; FATTY LIVER; HUMAN; LIPID STORAGE; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; ANIMAL; DISEASE MODEL; METABOLISM; PATHOLOGY;

ADIPOSITY; ANIMALS; DISEASE MODELS, ANIMAL; ETHANOL; FATTY LIVER; HUMANS; OBESITY; PROTEINS;

EID: 85006106052     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.1136/jim-2016-000204     Document Type: Article

References (34)

1. Sozio MS, Liangpunsakul S, Crabb D. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Semin Liver Dis 2010;30:378-90.
2. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011;141:1572-85.
3. Mandrekar P, Bataller R, Tsukamoto H, et al. Alcoholic hepatitis: translational approaches to develop targeted therapies. Hepatology Published Online First: 3 Mar 2016. doi:10.1002/hep.28530
4. Kondili LA, Taliani G, Cerga G, et al. Correlation of alcohol consumption with liver histological features in non-cirrhotic patients. Eur J Gastroenterol Hepatol 2005;17:155-9.
5. Badaloo A, Reid M, Soares D, et al. Relation between liver fat content and the rate of VLDL apolipoprotein B-100 synthesis in children with protein-energy malnutrition. Am J Clin Nutr 2005;81:1126-32.
6. Huang J, Iqbal J, Saha PK, et al. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology 2007;46:147-57.
7. Xu MJ, Cai Y, Wang H, et al. Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. Gastroenterology 2015;149:1030-41.e6.
8. Liang L, Zhao M, Xu Z, et al. Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family. Biochem J 2003;370:195-203.
9. Matsusue K, Kusakabe T, Noguchi T, et al. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab 2008;7:302-11.
10. Gong J, Sun Z, Li P. CIDE proteins and metabolic disorders. Curr Opin Lipidol 2009;20:121-6.
11. Xu L, Zhou L, Li P. CIDE proteins and lipid metabolism. Arterioscler Thromb Vasc Biol 2012;32:1094-8.
12. Xu X, Park JG, So JS, et al. Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis. Hepatology 2015;61:857-69.
13. Keller P, Petrie JT, De Rose P, et al. Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem 2008;283:14355-65.
14. Greenberg AS, Coleman RA, Kraemer FB, et al. The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest 2011;121:2102-10.
15. Ueno M, Shen WJ, Patel S, et al. Fat-specific protein 27 modulates nuclear factor of activated T cells 5 and the cellular response to stress. J Lipid Res 2013;54:734-43.
16. Puri V, Konda S, Ranjit S, et al. Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J Biol Chem 2007;282:34213-18.
17. Grahn TH, Kaur R, Yin J, et al. Fat-specific protein 27 (FSP27) interacts with adipose triglyceride lipase (ATGL) to regulate lipolysis and insulin sensitivity in human adipocytes. J Biol Chem 2014;289:12029-39.
18. Singh M, Kaur R, Lee MJ, et al. Fat-specific protein 27 inhibits lipolysis by facilitating the inhibitory effect of transcription factor Egr1 on transcription of adipose triglyceride lipase. J Biol Chem 2014;289:14481-7.
19. Robenek H, Robenek MJ, Troyer D. PAT family proteins pervade lipid droplet cores. J Lipid Res 2005;46:1331-8.
20. Danesch U, Hoeck W, Ringold GM. Cloning and transcriptional regulation of a novel adipocyte-specific gene, FSP27. CAAT-enhancer-binding protein (C/EBP) and C/EBP-like proteins interact with sequences required for differentiation-dependent expression. J Biol Chem 1992;267:7185-93.
21. Williams PM, Chang DJ, Danesch U, et al. CCAAT/enhancer binding protein expression is rapidly extinguished in TA1 adipocyte cells treated with tumor necrosis factor. Mol Endocrinol 1992;6:1135-41.
22. Yu S, Matsusue K, Kashireddy P, et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 2003;278:498-505.
23. Puri V, Ranjit S, Konda S, et al. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci USA 2008;105:7833-8.
24. Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004;89:463-78.
25. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46:3-10.
26. Vilà-Brau A, De Sousa-Coelho AL, Gonçalves JF, et al. Fsp27/CIDEC is a CREB target gene induced during early fasting in liver and regulated by FA oxidation rate. J Lipid Res 2013;54:592-601.
27. Aibara D, Matsusue K, Matsuo K, et al. Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver. Biol Pharm Bull 2013;36:1766-72.
28. Bertola A, Mathews S, Ki SH, et al. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 2013;8: 627-37.
29. Naveau S, Dobrin AS, Balian A, et al. Body fat distribution and risk factors for fibrosis in patients with alcoholic liver disease. Alcohol Clin Exp Res 2013;37:332-8.
30. Hart CL, Morrison DS, Batty GD, et al. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 2010;340:c1240.
31. Xu J, Lai KK, Verlinsky A, et al. Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol 2011;55:673-82.
32. Chang B, Xu MJ, Zhou Z, et al. Short-or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1. Hepatology 2015;62:1070-85.
33. Wiedemann MS, Wueest S, Item F, et al. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance. Am J Physiol Endocrinol Metab 2013;305:E388-95.
34. Langhi C, Baldán Á. CIDEC/FSP27 is regulated by peroxisome proliferator-activated receptor alpha and plays a critical role in fasting-and diet-induced hepatosteatosis. Hepatology 2015;61:1227-38.